Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response

References

• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• NguyenDXBosPDMassagueJMetastasis: from dissemination to organ-specific colonizationNat Rev Cancer20099427428419308067
   PubMed Web of Science ®Google Scholar
• PantelKAlix-PanabièresCReal-time liquid biopsy in cancer patients: fact or fiction?Cancer Res201373216384638824145355
   PubMed Web of Science ®Google Scholar
• YuMBardiaAWittnerBSCirculating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal compositionScience2013339611958058423372014
   PubMed Web of Science ®Google Scholar
• GruberILandenbergerNStaeblerAHahnMWallwienerDFehmTRelationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancerAnticancer Res20133352233223823645781
   PubMed Web of Science ®Google Scholar
• CleverDRoychoudhuriRConstantinidesMGOxygen sensing by T cells establishes an immunologically tolerant metastatic nicheCell201616651117113127565342
   PubMedGoogle Scholar
• MegoMGaoHCohenENCirculating tumor cells (CTC) are associated with defects in adaptive immunity in patients with inflammatory breast cancerJ Cancer2016791095110427326253
   PubMedGoogle Scholar
• MittalDGubinMMSchreiberRDSmythMJNew insights into cancer immunoediting and its three component phases-elimination, equilibrium and escapeCurr Opin Immunol201427625
   Google Scholar
• WangJWangKXuJHuangJZhangTPrognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysisPLoS One2013811e7807024223761
   PubMed Web of Science ®Google Scholar
• WanJWGaoMZHuRJA preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancerAnn Transl Med201532235226807407
   PubMedGoogle Scholar
• PunnooseEAAtwalSLiuWEvaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinibClin Cancer Res20121882391240122492982
   PubMed Web of Science ®Google Scholar
• ThalgottMRackBEiberMCategorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patientsBMC Cancer20151545826051431
   PubMed Web of Science ®Google Scholar
• GoldstrawPChanskyKCrowleyJThe IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancerJ Thorac Oncol2016111395126762738
   PubMed Web of Science ®Google Scholar
• TsongalisGJBranched DNA technology in molecular diagnosticsAm J Clin Pathol2006126344845316880139
   PubMedGoogle Scholar
• WuSLiuSLiuZClassification of circulating tumor cells by epithelial-mesenchymal transition markersPLoS One2015104e012397625909322
   PubMed Web of Science ®Google Scholar
• Bednarz-KnollNAlix-PanabièresCPantelKPlasticity of disseminating cancer cells in patients with epithelial malignanciesCancer Metastasis Rev2012313–467368722733306
   PubMed Web of Science ®Google Scholar
• HanssenAWagnerJGorgesTMCharacterization of different CTC subpopulations in non-small cell lung cancerSci Rep201662801027302574
   PubMedGoogle Scholar
• BarriereGRiouallonARenaudieJTartaryMRigaudMMesenchymal characterization: alternative to simple CTC detection in two clinical trialsAnticancer Res20123283363336922843916
   PubMedGoogle Scholar
• TamWLWeinbergRAThe epigenetics of epithelial-mesenchymal plasticity in cancerNat Med201319111438144924202396
   PubMed Web of Science ®Google Scholar
• JoosseSAGorgesTMPantelKBiology, detection, and clinical implications of circulating tumor cellsEMBO Mol Med201471111
   PubMed Web of Science ®Google Scholar
• GodinhoSAPiconeRBuruteMOncogene-like induction of cellular invasion from centrosome amplificationNature2014510750316717124739973
   PubMedGoogle Scholar
• AcetoNBardiaAMiyamotoDTCirculating tumor cell clusters are oligoclonal precursors of breast cancer metastasisCell201415851110112225171411
   PubMed Web of Science ®Google Scholar
• FörnvikDAnderssonIDustlerMNo evidence for shedding of circulating tumor cells to the peripheral venous blood as a result of mammographic breast compressionBreast Cancer Res Treat2013141218719523990353
   PubMedGoogle Scholar
• Celià-TerrassaTMeca-CortésOMateoFEpithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cellsJ Clin Invest201212251849186822505459
   PubMed Web of Science ®Google Scholar
• PantelKBrakenhoffRHDissecting the metastatic cascadeNat Rev Cancer20044644845615170447
   PubMed Web of Science ®Google Scholar
• RiethdorfSWikmanHPantelKReview: biological relevance of disseminated tumor cells in cancer patientsInt J Cancer200812391991200618712708
   PubMed Web of Science ®Google Scholar
• KangYPantelKTumor cell dissemination: emerging biological insights from animal models and cancer patientsCancer Cell201323557358123680145
   PubMed Web of Science ®Google Scholar
• PantelKAlix-PanabièresCBone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patientsBonekey Rep2014358425419458
   PubMedGoogle Scholar
• BidardFCPeetersDJFehmTClinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient dataLancet Oncol201415440641424636208
   PubMed Web of Science ®Google Scholar
• KrebsMGRenehanAGBackenACirculating tumor cell enumeration in a phase II trial of a four-drug regimen in advanced colorectal cancerClin Colorectal Cancer201514211512225680623
   PubMedGoogle Scholar
• KitamuraTQianBZPollardJWImmune cell promotion of metastasisNat Rev Immunol2015152738625614318
   PubMed Web of Science ®Google Scholar
• PancioneMGiordanoGRemoAImmune escape mechanisms in colorectal cancer pathogenesis and liver metastasisJ Immunol Res2014201468687924741617
   PubMed Web of Science ®Google Scholar
• LarbiAZelbaHGoldeckDPawelecGInduction of HIF-1alpha and the glycolytic pathway alters apoptotic and differentiation profiles of activated human T cellsJ Leukoc Biol201087226527319892848
   PubMedGoogle Scholar
• WangRGreenDRMetabolic checkpoints in activated T cellsNat Immunol2012131090791522990888
   PubMed Web of Science ®Google Scholar
• ChangCHQiuJO’SullivanDMetabolic competition in the tumor microenvironment is a driver of cancer progressionCell201516261229124126321679
   PubMed Web of Science ®Google Scholar
• TosoliniMKirilovskyAMlecnikBClinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancerCancer Res20117141263127121303976
   PubMed Web of Science ®Google Scholar